Fennec Pharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
42.61 |
46.89 |
73.58 |
90.73 |
121.45 |
160.91 |
| Przychód Δ r/r |
0.00% |
10.05% |
56.92% |
23.30% |
33.86% |
32.50% |
| Przychód (min) |
29.64 |
39.74 |
65.48 |
88.56 |
107.31 |
142.18 |
| Przychód (max) |
55.58 |
54.04 |
86.37 |
92.89 |
139.12 |
184.33 |
| EBITDA (średnia) |
-12.83 |
-14.12 |
-22.16 |
-27.33 |
-36.58 |
-48.47 |
| EBIT (średnia) |
-13.13 |
-14.45 |
-22.68 |
-27.97 |
-37.44 |
-49.60 |
| EBIT % |
-30.83% |
-30.83% |
-30.83% |
-30.83% |
-30.83% |
-30.83% |
| Zysk netto (średni) |
-1.96 |
4.94 |
24.85 |
43.58 |
65.94 |
99.30 |
| Zysk netto % |
-4.60% |
10.54% |
33.77% |
48.04% |
54.29% |
61.71% |
| EPS (średnia) |
-0.07 |
0.18 |
0.89 |
1.56 |
2.42 |
3.64 |
| Liczba analityków (Przychody) |
4 |
3 |
5 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
3 |
3 |
4 |
3 |
1 |
1 |
| symbol |
FENC |
FENC |
FENC |
FENC |
FENC |
FENC |